In this podcast series, we’ll address some of the most frequently asked questions veterinarians have about STELFONTA, providing expert insights and practical guidance.
Join Dr. Cassie McGee, a Clinical and Research Veterinarian at QBiotics, and Dr. Justine Campbell, Senior Technical Services Veterinarian for STELFONTA worldwide and a private practice owner. With extensive experience, Justine has personally treated over 500 cases using STELFONTA. In Episodes 4 and 6, Cassie is also joined by Dr. Pamela Jones, a board-certified radiation and medical veterinary oncologist from the U.S., who played a pivotal role in the global launch of STELFONTA.
EPISODE 1: Client conversations, engaging and preparing pet owners for successful STELFONTA treatment
Dr Justine Campbell talks to Dr Cassie McGee about how she engages clients in the STELFONTA conversation. In this episode they discuss: Client preference for STELFONTA over surgery, sharing success rates and the chance of a second injection. Engaging them in the process including essential medications, post treatment care and what to expect at the recheck after 28 days.
Download the STELFONTA Pet Owner guide leaflet
Download the Stelfonta Medication Tracker for Pet Owners leaflet
EPISODE 2: STELFONTA case selection – what makes a great case
Dr Justine Campbell has personally treated over 500 dogs with STELFONTA in clinical trials and private practice, and leads Pharmacovigilance for STELFONTA globally, so no one is better qualified to share what makes a good STELFONTA case…and what doesn’t. Justine chats to Dr Cassie McGee about tumour factors, patient considerations and the type of pet owners who prefer STELFONTA when engaged fully.
Download the Practical STELFONTA use leaflet
EPISODE 3: Minimising pain after STELFONTA injection
Dr Justin Campbell talks about the importance of proactive pre-emptive pain medication to keep patients comfortable during and after STELFONTA injection: the mode of action and inflammatory response, the essential concomitant medication schedule and pain medications for keeping the tumour site comfortable after STELFONTA.
Download the Stelfonta Tips for Pain Management leaflet
EPISODE 4: Staging and Grading with STELFONTA
Dr Pamela Jones, board certified oncologist, discusses staging and grading with STELFONTA. Covered in this episode: How to stage and grade with STELFONTA, histopathology biopsy versus cytological grading along with clinical assessment staging and when to refer to an oncologist.
Download the Staging and Grading Mast Cell Tumours with Stelfonta Treatment FAQ's leaflet
EPISODE 5: Concomitant Medications and reducing risk of mast cell degranulation
Dr Justine Campbell talks about Mast Cell Degranulation – what it is and how to reduce the risk: how mast cell degranulation impacts the body locally and systemically and the role of concomitant medications in reducing the risk of degranulation. The medication schedule and tips for administering essential medications and what to do if a dose is missed.
Download the STELFONTA Concomitant Medications leaflet
EPISODE 6: Wound healing post STELFONTA treatment
Dr Pamela Jones, board certified oncologist, and Dr Justine Campbell, Senior Technical Services Veterinarian at QBiotics discuss the temporary wound created after STELFONTA injection has removed a mast cell tumour. In this episode, how STELFONTA’s unique mode of action causes a temporary wound, the predictability of the wound and the STELFONTA wound healing process.
Download the Stelfonta Tips for Wound Management leaflet
EPISODE 7: Top tips for STELFONTA treatment day
Dr Justine Campbell shares tips for successful treatment with STELFONTA injection, acquired from treating over 500 dogs to date. Justine discusses tips for essential medication compliance, sedation on injection day and pre-emptive pain relief. Also discussed is how to accurately measure the tumour volume and dose, administering the drug correctly, especially small or dense tumours and Mast Cell Monday.
Download the STELFONTA First Use Guide (Practical Aspects) leaflet
EPISODE 8: Assessing for Complete Response following STELFONTA Injection
Dr Justine Campbell explains how to assess for a complete response following STELFONTA. How do we know if a second injection may be required? When is the best time to assess the site? What to look out for in a visual assessment? How does the abscopal effect apply to STELFONTA sites? And factors that can contribute to lack of efficacy: Tumour, Administration and Patient considerations.
Download the Stelfonta Wait until 28 leaflet
Do you have a case you'd like to treat with STELFONTA? Our veterinarians are available to discuss STELFONTA and provide guidance for individual cases, please email stelfonta@virbac.com.au or call 1800 242 100
Click the button below to see MCTs treated with STELFONTA in Australian veterinary clinics